---
title: "Eli Lilly spent nearly $500 million to acquire the rights to MeiraGTx's gene therapy for congenital blindness"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/265213648.md"
description: "Eli Lilly has reached a licensing agreement with MeiraGTx worth over $475 million to obtain the rights to a gene therapy for the treatment of rare hereditary blindness diseases. MeiraGTx will receive a $75 million upfront payment and has the opportunity to earn over $400 million in milestone payments, as well as being eligible for tiered royalties"
datetime: "2025-11-10T19:14:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265213648.md)
  - [en](https://longbridge.com/en/news/265213648.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265213648.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/265213648.md) | [English](https://longbridge.com/en/news/265213648.md)


# Eli Lilly spent nearly $500 million to acquire the rights to MeiraGTx's gene therapy for congenital blindness

American gene therapy company MeiraGTx (MGTX.US) announced that it has reached a potential licensing agreement worth over $475 million with Eli Lilly (LLY.US), granting Eli Lilly rights to an experimental gene therapy for the treatment of rare hereditary blindness diseases.

Under the agreement, MeiraGTx will receive a $75 million upfront payment and has the opportunity to earn over $400 million in milestone payments. Additionally, the company is eligible to receive tiered royalties on the licensed product

### 相關股票

- [MeiraGTx (MGTX.US)](https://longbridge.com/zh-HK/quote/MGTX.US.md)
- [Eli Lilly (LLY.US)](https://longbridge.com/zh-HK/quote/LLY.US.md)

## 相關資訊與研究

- [MeiraGTx Holdings PLC $MGTX Shares Bought by Hennion & Walsh Asset Management Inc.](https://longbridge.com/zh-HK/news/281338264.md)
- [Eli Lilly: Foundayo will be available with prescriptions accepted immediately and shipping from April 6](https://longbridge.com/zh-HK/news/281395595.md)
- [Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | LLY Stock News](https://longbridge.com/zh-HK/news/281171668.md)
- [InSilico Medicine's Loss Widens in 2025; Enters Licensing Agreement With Eli Lilly](https://longbridge.com/zh-HK/news/280951810.md)
- [<![CDATA[Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments]]>](https://longbridge.com/zh-HK/news/281203519.md)